Literature DB >> 11171101

Characterization of KIAA1427 protein as an atypical synaptotagmin (Syt XIII).

M Fukuda1, K Mikoshiba.   

Abstract

Synaptotagmin (Syt) belongs to a family of type-I membrane proteins and is a protein that consists of a short extracellular N-terminus, a single transmembrane domain, two C2 domains and a short C-terminus. Here, we cloned and characterized a mouse orthologue of human KIAA1427 protein as an atypical Syt (named Syt XIII). Subcellular fractionation and antibody-uptake experiments indicate that Syt XIII is indeed a type-I membrane protein, but, unlike other Syt isoforms, lacks an N-terminal extracellular domain. Syt XIII C2 domains show relatively little similarity to Syt I (less than 35% identity at the amino acid level), and lack key amino acids responsible for Ca2+ binding. Because of these substitutions, the Syt XIII C2 domains did not show Ca2+-dependent phospholipid-binding activity, and Syt XIII is thus classified as a Ca2+ -independent isoform. By contrast, the Syt XIII C-terminal domain is highly homologous with other Syt isoforms and can function as a common receptor for neurexin Ialpha in vitro. Since Syt XIII is expressed in various tissues outside the brain, Syt XIII may be involved in constitutive vesicle transport.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171101      PMCID: PMC1221650          DOI: 10.1042/0264-6021:3540249

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  55 in total

1.  Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin.

Authors:  Y A Ushkaryov; A G Petrenko; M Geppert; T C Südhof
Journal:  Science       Date:  1992-07-03       Impact factor: 47.728

2.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

3.  Role of the conserved WHXL motif in the C terminus of synaptotagmin in synaptic vesicle docking.

Authors:  M Fukuda; J E Moreira; V Liu; M Sugimori; K Mikoshiba; R R Llinás
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

4.  Inositol-1,3,4,5-tetrakisphosphate binding to C2B domain of IP4BP/synaptotagmin II.

Authors:  M Fukuda; J Aruga; M Niinobe; S Aimoto; K Mikoshiba
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

5.  Structure of the first C2 domain of synaptotagmin I: a novel Ca2+/phospholipid-binding fold.

Authors:  R B Sutton; B A Davletov; A M Berghuis; T C Südhof; S R Sprang
Journal:  Cell       Date:  1995-03-24       Impact factor: 41.582

6.  Synaptic function is impaired but not eliminated in C. elegans mutants lacking synaptotagmin.

Authors:  M L Nonet; K Grundahl; B J Meyer; J B Rand
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

7.  Rabphilin-3A, a putative target protein for smg p25A/rab3A p25 small GTP-binding protein related to synaptotagmin.

Authors:  H Shirataki; K Kaibuchi; T Sakoda; S Kishida; T Yamaguchi; K Wada; M Miyazaki; Y Takai
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

8.  Doc2: a novel brain protein having two repeated C2-like domains.

Authors:  S Orita; T Sasaki; A Naito; R Komuro; T Ohtsuka; M Maeda; H Suzuki; H Igarashi; Y Takai
Journal:  Biochem Biophys Res Commun       Date:  1995-01-17       Impact factor: 3.575

9.  A role for synaptotagmin (p65) in regulated exocytosis.

Authors:  L A Elferink; M R Peterson; R H Scheller
Journal:  Cell       Date:  1993-01-15       Impact factor: 41.582

10.  Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse.

Authors:  M Geppert; Y Goda; R E Hammer; C Li; T W Rosahl; C F Stevens; T C Südhof
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

View more
  12 in total

1.  The N-terminal cysteine cluster is essential for membrane targeting of B/K protein.

Authors:  M Fukuda; K Mikoshiba
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

2.  Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.

Authors:  Carsten W Lederer; Antonietta Torrisi; Maria Pantelidou; Niovi Santama; Sebastiano Cavallaro
Journal:  BMC Genomics       Date:  2007-01-23       Impact factor: 3.969

3.  The C2A domain of synaptotagmin-like protein 3 (Slp3) is an atypical calcium-dependent phospholipid-binding machine: comparison with the C2A domain of synaptotagmin I.

Authors:  Mitsunori Fukuda
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

4.  The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer.

Authors:  Koki Nakanishi; Mitsuro Kanda; Shinichi Umeda; Chie Tanaka; Daisuke Kobayashi; Masamichi Hayashi; Suguru Yamada; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2019-05-04       Impact factor: 7.370

5.  Alternative splicing isoforms of synaptotagmin VII in the mouse, rat and human.

Authors:  Mitsunori Fukuda; Yukie Ogata; Chika Saegusa; Eiko Kanno; Katsuhiko Mikoshiba
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

6.  Comparative analysis of tandem C2 domains from the mammalian synaptotagmin family.

Authors:  Colin Rickman; Molly Craxton; Shona Osborne; Bazbek Davletov
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

7.  The AP2 binding site of synaptotagmin 1 is not an internalization signal but a regulator of endocytosis.

Authors:  N Jarousse; R B Kelly
Journal:  J Cell Biol       Date:  2001-08-13       Impact factor: 10.539

8.  Alternative splicing variations in mouse CAPS2: differential expression and functional properties of splicing variants.

Authors:  Tetsushi Sadakata; Miwa Washida; Teiichi Furuichi
Journal:  BMC Neurosci       Date:  2007-04-12       Impact factor: 3.288

9.  Synaptotagmin gene content of the sequenced genomes.

Authors:  Molly Craxton
Journal:  BMC Genomics       Date:  2004-07-06       Impact factor: 3.969

10.  Synaptotagmin 13 is neuroprotective across motor neuron diseases.

Authors:  M Nizzardo; M Taiana; F Rizzo; J Aguila Benitez; J Nijssen; I Allodi; V Melzi; N Bresolin; G P Comi; E Hedlund; S Corti
Journal:  Acta Neuropathol       Date:  2020-02-17       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.